Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrhoeal disease. [electronic resource]
- Annals of Saudi medicine
- 332-6 p. digital
Publication Type: Corrected and Republished Article; Journal Article
0256-4947
10.5144/0256-4947.2004.332 doi
Acute Disease Anti-Infective Agents--therapeutic use Ciprofloxacin--therapeutic use Communicable Diseases, Emerging--drug therapy Drug Resistance, Bacterial Dysentery--drug therapy Feces--microbiology Humans Nalidixic Acid--therapeutic use Prevalence Salmonella--isolation & purification Salmonella Infections--drug therapy Saudi Arabia--epidemiology